CIVILICA We Respect the Science
(ناشر تخصصی کنفرانسهای کشور / شماره مجوز انتشارات از وزارت فرهنگ و ارشاد اسلامی: ۸۹۷۱)

Possible Benefits of Paclitaxel Therapy for COVID-۱۹

عنوان مقاله: Possible Benefits of Paclitaxel Therapy for COVID-۱۹
شناسه ملی مقاله: JR_PBRE-8-2_001
منتشر شده در در سال 1401
مشخصات نویسندگان مقاله:

Marzieh Pashmforosh - Department of Basic Sciences, Faculty of Medical Sciences, Behbahan University of Medical Sciences, Behbahan, Iran.
Saeedeh Shariati - Department of Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Hamideh Aghaei Nezhad - Department of Basic Sciences, Faculty of Medical Sciences, Behbahan University of Medical Sciences, Behbahan, Iran.
Mojtaba Haghighat - Department of Basic Sciences, Faculty of Medical Sciences, Behbahan University of Medical Sciences, Behbahan, Iran.

خلاصه مقاله:
The coronavirus disease ۲۰۱۹ (COVID-۱۹) was reported in Wuhan, China, in late December ۲۰۱۹ and soon became the most serious global health challenge due to the high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) is a single-stranded RNA virus and belongs to the large Coronaviridae family [۱].

کلمات کلیدی:
COVID-۱۹, Paclitaxel, Anti-inflammatory, Antiviral activity

صفحه اختصاصی مقاله و دریافت فایل کامل: https://civilica.com/doc/1872342/